UC Market Gets Increasingly Crowded – But High Unmet Need Remains

Ulcerative Colitis Market Snapshot

Market Snapshot: The ulcerative colitis market looks set to experience strong pricing pressure over the next three to five years, with leading players losing exclusivity for their drugs and a flood of novel entrants set to hit the market.

• Source: Alamy

Six new drugs are set to enter the market for ulcerative colitis (UC) within the next three years, just as some established therapies for the disease, including AbbVie Inc.’s Humira, begin to face generic competition.

A new report from Datamonitor Healthcare says the upcoming changes will lead to major pricing pressures in the field...

More from New Products

More from Scrip